News
Namita Thapar’s Emcure Pharmaceuticals shares made a robust debut on July 10, listing at Rs 1,325.05, which is 31.5 percent above the issue price of Rs 1,008. This follows a successful Initial ...
Namita Thapar shares advice for 70-hour week working professionals. Recently, Namita Thapar in an interview with Humans of Bombay highlighted the effects of long working hours on mental health and ...
Recently, Namita Thapar in an interview with Humans of Bombay highlighted the effects of long working hours on mental health and family life. Her advice, especially to those who work 70-hour weeks ...
Namita Thapar and Anupam Mittal appeared together on 'Shark Tank India'. It's been several months, but the debate on India's work productivity, sparked by Infosys founder NR Narayana Murthy's '70 ...
During an interview with Humans of Bombay, Shark Tank India judges Namita Thapar and Anupam Mittal shared conflicting perspectives on work productivity, leading to a heated exchange.
As the debate around work-life balance intensified, Shark Tank judge and Executive Director at Emcure Pharmaceuticals Namita Thapar made a bold statement against the advocates of a 70-hour work week.
In a post on X, Thapar celebrated this milestone, highlighting Go-Zero’s unique value proposition of zero sugar, half the calories, and irresistible flavours. Zero Sugar, Rs 5 crore sales!
Hosted on August 24 at Jaipur’s Techno Hub, the launch event was graced by Namita Thapar, an angel investor and the executive director of Emcure Pharmaceuticals.
Namita Thapar's Emcure Pharmaceuticals had a strong stock market debut, with shares listing 31.5% above the issue price. ... In an exclusive interview with ETimes TV previously, ...
In a recent interview Shark Tank India’s Namita Thapar and Anupam Mittal expressed their contrasting views. Sunday, Jul 06, 2025. New Delhi o C. Subscribe. Sign in. My Account. Subscribe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results